BackLisata Therapeutics Overview

Lisata Therapeutics Receivables

Track Lisata Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-501000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lisata Therapeutics Receivables History

Loading

Lisata Therapeutics vs. peers: Receivables Comparison

Loading

Lisata Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lisata Therapeutics (LSTA) FAQ

Lisata Therapeutics (LSTA) currently reports a receivables of $0 as of June 2026. That compares with $500K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Lisata Therapeutics's receivables history and peer comparisons.

Lisata Therapeutics's receivables decreased from $500K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lisata Therapeutics reported $0 in receivables as of June 2026. That compares with $500K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lisata Therapeutics, and consider following LSTA for alerts when major investors trade the stock.

Lisata Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LSTA with unrelated industries.